Article History
Received: 8 July 2022
Accepted: 9 July 2022
First Online: 2 August 2022
Declarations
:
: LFM—None to declare. TES—employee of and shareholder in Inflammatix, Inc. PP—received fees for lecture from Gilead and Pfizer, consulting from MSD and Sanofi and unrestricted research grant from Abionic.
Free to read: This content has been made available to all.